From pharmacy to lab of the world: India’s AI-powered healthcare leap begins at IIMA
Union Minister of State for Health & Family Welfare and Chemicals & Fertilisers Anupriya Patel addresses ...
Tag: Zydus Lifesciences
125 years of innovation, enterprise and healing find a living digital home
IIMA Archives and Indian Pharmaceutical Alliance join hands to document the people, institutions and milestones behind India’s global pharma rise ...
Zydus unveils ANYRA™: India’s first indigenous aflibercept biosimilar to transform affordable retinal care
Breakthrough biosimilar ANYRA™ expands access to advanced biologic therapy for sight-threatening retinal diseases Agreement with Regeneron and Bayer strengthens innovation ...
Zydus Lifesciences secures USFDA tentative nod for Cancer Drug Olaparib Tablets
Approval covers 100 mg and 150 mg strengths; drug used in treating ovarian, breast, pancreatic and prostate cancers With this, ...
Q2 results: Zydus Lifesciences net profit rises 14% to ₹911 crore from ₹801 crore
The firm reports double-digit growth in Q2, revenue up 20% Research & Development (R&D) investments for the quarter stands at ...
Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast
Usnoflast, is a “First-in-class” NLRP3 inhibitor to demonstrate proof-of-concept in Phase 2(a) clinical study in ALS patients Usnoflast was well-tolerated ...
Zydus Lifesciences gets USFDA nod for marketing generic Parkinson’s drug
Zydus receives final approval from USFDA for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg Eligible for ...
Q1FY25 results: Zydus Lifesciences net profit rises 31% to Rs 1,420 cr
Company receives USFDA approval for Valbenazine Capsules Revenue from operations at Rs. 62,075 mn, up 21% YoY Research & Development ...
